STE - Steris Plc
90.51 +0.01 (0.01%)
After hours: 5:07PM EDT
| Previous Close | 90.79 |
| Open | 90.98 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 90.21 - 90.98 |
| 52 Week Range | 63.80 - 91.18 |
| Volume | 287,539 |
| Avg. Volume | 393,906 |
| Market Cap | 7.69B |
| Beta | 1.12 |
| PE Ratio (TTM) | 64.74 |
| EPS (TTM) | 1.4 |
| Earnings Date | Nov 1, 2017 |
| Forward Dividend & Yield | 1.24 (1.39%) |
| Ex-Dividend Date | 2017-08-25 |
| 1y Target Est | 94.00 |
- GlobeNewswire•14 hours ago
STERIS to Announce Fiscal 2018 Second Quarter Financial Results on November 1, 2017
LEICESTER, U.K. - October 18, 2017- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced today that it will host a conference call to discuss its fiscal 2018 second quarter ...
- Capital Cube•2 days ago
ETFs with exposure to STERIS Plc : October 16, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to STERIS Plc Here are 5 ETFs with the largest exposure to STE-US. Comparing the performance and risk of STERIS Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
- Zacks•5 days ago
5 MedTech Momentum Picks Investors Will Love
In a volatile political environment, seasoned investors should focus on momentum stocks as winning bets to tide over the uncertainty.
Markit•6 days agoSee what the IHS Markit Score report has to say about Steris PLC.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
- Zacks•8 days ago
The Zacks Analyst Blog Highlights: IDEXX Laboratories, Steris, K2M Group Holdings, Tandem Diabetes Care and Intersect ENT
The Zacks Analyst Blog Highlights: IDEXX Laboratories, Steris, K2M Group Holdings, Tandem Diabetes Care and Intersect ENT
- Zacks•8 days ago
5 MedTech Stocks for Stellar Returns in Q3
Here we take a sneak peek into two burning issues that are likely to impact the quarterly numbers in the MedTech fraternity.
- Zacks•8 days ago
4 Top Growth Picks as MedTech Battle Rages On
Trump's Obamacare replacement saga has made growth picks great opportunities for investors in MedTech sector.
- Capital Cube•15 days ago
ETFs with exposure to STERIS Plc : October 3, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to STERIS Plc Here are 5 ETFs with the largest exposure to STE-US. Comparing the performance and risk of STERIS Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cube•17 days agoSTERIS Plc :STE-US: Earnings Analysis: Q1, 2018 By the Numbers : October 2, 2017
Categories: Yahoo FinanceGet free summary analysis STERIS Plc reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of STERIS Plc – Cantel Medical Corp. (CMD-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 607.96 million, Net Earnings of USD 58.08 million. Gross ... Read more (Read more...)
- Simply Wall St.•19 days ago
When Should You Sell Steris Plc (STE)?
Steris Plc (NYSE:STE) is currently trading at a trailing P/E of 62.5x, which is higher than the industry average of 42.6x. While this makes STE appear like a stock toRead More...
- Zacks•22 days ago
STERIS (STE) Rides on Organic Growth, Stiff Contest a Threat
STERIS' (STE) consistent strong organic all-segment growth performance impresses investors. Additionally, growth in free cash flow reserve denotes the company's solid cash position.
Capital Cube•27 days agoSTERIS Plc : STE-US: Dividend Analysis : August 29th, 2017 (record date) : By the numbers : September 21, 2017
Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing STERIS Plc with the following peers – Hill-Rom Holdings, Inc., Stryker Corporation, Cantel Medical Corp., Invacare Corporation, Thermo Fisher Scientific Inc., Owens & Minor, Inc., Ecolab Inc., CONMED Corporation, 3M Company and Johnson & Johnson (HRC-US, SYK-US, CMD-US, IVC-US, TMO-US, OMI-US, ECL-US, CNMD-US, MMM-US and ... Read more (Read more...)
- Investor's Business Daily•last month
How Much Higher Can Medtech Climb As Investors Flee Pharma?
Intuitive Surgical, Varian and Steris are helping the medtech sector to hit multiyear highs, but the sector is facing soft utilization and volumes, hinting at a potential downturn.
Markit•last monthSee what the IHS Markit Score report has to say about Steris PLC.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Markit•last monthSee what the IHS Markit Score report has to say about Steris PLC.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
- ACCESSWIRE•2 months ago
Earnings Review and Free Research Report: Steris Reported Strong Results with Growth in Net Income and Earnings
Research Desk Line-up: Medtronic Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 29, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Steris PLC (NYSE: STE ), which can ...
- Zacks•2 months ago
Stryker (SYK) to Gain From Solid Portfolio and Acquisitions
Stryker's (SYK) diverse product portfolio alongside acquisition-driven strategy would continue to boost growth prospects. However, competition in the Chinese market raise concern.
- Zacks•2 months ago
Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now
IDEXX Laboratories (IDXX) rides high on strength across all segments, with significant contributions from the Companion Animal Group business. Moreover, a raised guidance buoys optimism.
- Zacks•2 months ago
Here's Why Investors Should Buy Align Technology (ALGN) Now
Align Technology (ALGN) continues to ride high on robust growth in the Invisalign space.
Zacks•2 months agoHaemonetics Plasma Arm Grows Strong, Blood Center Sluggish
Haemonetics (HAE) registers strong top-line growth, banking on Plasma, TEG, hemostasis management as well as a strong cash position. Blood Center drag continues.
- Zacks•2 months ago
Varian (VAR) Rides on Oncology and Proton Therapy Businesses
Varian Medical's (VAR) oncology and Proton therapy business' growth prospects remain impressive. However, competition in the radiotherapy space raise concern.
- Zacks•2 months ago
Civitas Solutions (CIVI) Q3 Earnings Beat, Revenues Miss
Civitas Solutions (CIVI) gains on strength in Post-Acute Specialty Rehabilitation Services and Adult Day Health services in Q3. However, tweaked full-year 2017 guidance signals dull prospects.
- ACCESSWIRE•2 months ago
Featured Company News - Intuitive Surgical Splits Stock in Three for One Ratio
Research Desk Line-up: Steris Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 15, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Intuitive ...
- Zacks•2 months ago
Myriad Genetics (MYGN) Grows on Higher Cancer Test Volumes
Myriad Genetics (MYGN) rides high on strength in Molecular Diagnostics with significant contributions from GeneSight. Also, hereditary cancer testing continues to witness sequential growth.
- Zacks•2 months ago
STERIS (STE) Banks on Organic Growth, Competition Intense
STERIS' (STE) cost structure is likely to be enhanced through recent organizational changes.
